Prompt Cast
The Hidden Crisis of U.S. Hospital Drug Shortages Explained by Planet Money
Generated on February 26, 2026
TLDR A nurse describes the dire consequences of routine U.S. hospitals running out of essential drugs like epinephrine due to supply chain issues, while a healthcare economist delves into how manufacturing difficulties, low profitability for generics, and government regulations contribute significantly to these shortages.
Timestamped Summary
00:00
A nurse recounts the distressing reality of pervasive drug shortages in U.S. hospitals, with generic medications like epinephrine frequently unavailable due to supply chain issues.
03:37
A healthcare economist explains on Planet Money why simple, essential drugs frequently run out in U.S. hospitals due to supply chain issues and complex economic factors within the healthcare industry.
07:23
A healthcare economist on Planet Money explores the complex reasons behind frequent U.S. hospital generic injectable sterile drug shortages caused by supply chain issues, manufacturing problems, and regulatory factors like FDA inspections leading to closures or recalls.
10:44
A healthcare economist on Planet Money reveals U.S. hospital drug shortages stem from a lack of generic sterile injectable producers due to low profitability and supply chain disruforts, with manufacturers opting for higher-priced proprietary drugs or exiting the market entirely.
14:06
Why do low prices for generic sterile injectables lead manufacturers away from producing them, despite their essential nature?
17:45
Low prices for generic drugs in hospitals are caused by group purchasing organizations leveraging combined buying power, which undermines the price mechanism and contributes to recurring shortages.
21:24
Hospitals prioritize cost savings over resilient drug supply chains, exacerbating shortages caused by low pricing pressures and lack of incentives for both manufacturers and healthcare providers.
24:43
Hospitals' focus on cost savings over supply chain resilience leads to drug shortages, with potential solutions involving government intervention and changing hospital incentives.
